Detalhe da pesquisa
1.
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3317-3328, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875023
2.
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis.
Immunity
; 37(6): 1104-15, 2012 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23123062
3.
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.
Ann Rheum Dis
; 77(5): 706-713, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420200
4.
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
Hum Mol Genet
; 24(2): 582-96, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25205108
5.
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Ann Rheum Dis
; 75(11): 1909-1916, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009916
6.
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction.
Proc Natl Acad Sci U S A
; 109(47): 19403-7, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129637
7.
Response to: 'Comment on: 'Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al' by Isenberg.
Ann Rheum Dis
; 78(11): e122, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373881
8.
The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.
Arthritis Rheum
; 65(11): 2898-906, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23925905
9.
Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Arthritis Rheum
; 65(12): 3228-38, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982860
10.
miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.
J Am Soc Nephrol
; 24(7): 1073-87, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23723424
11.
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
Ann Rheum Dis
; 72(1): 118-28, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22858586
12.
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.
RMD Open
; 9(3)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541743
13.
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.
Lupus Sci Med
; 10(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717181
14.
The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland.
Rheumatology (Oxford)
; 51(9): 1557-62, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22562936
15.
Adrenomedullary response to glucagon in patients with primary Sjögren's syndrome.
Cell Mol Neurobiol
; 32(5): 903-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22350211
16.
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.
Arthritis Rheum
; 63(2): 535-44, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21280008
17.
circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis.
Oxid Med Cell Longev
; 2022: 2769487, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267809
18.
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus.
Ann Rheum Dis
; 70(12): 2071-4, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873334
19.
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.
Blood
; 113(21): 5125-33, 2009 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19299332
20.
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.
Sci Transl Med
; 13(595)2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039741